Looking for Sentiment Analysis? Discover the most popular stocks on Reddit by using our Sentiment Tracker
Market Cap 165.93M P/E - EPS this Y 25.60% Ern Qtrly Grth -
Income -17.98M Forward P/E -10.38 EPS next Y 9.00% 50D Avg Chg -4.00%
Sales 28.07M PEG -0.61 EPS past 5Y - 200D Avg Chg -22.00%
Dividend N/A Price/Book 5.09 EPS next 5Y 30.00% 52W High Chg -60.00%
Recommedations 1.70 Quick Ratio 2.24 Shares Outstanding 27.60M 52W Low Chg 8.00%
Insider Own 7.85% ROA -23.17% Shares Float 25.24M Beta 1.12
Inst Own 30.30% ROE -60.40% Shares Shorted/Prior 709.40K/805.36K Price 6.75
Gross Margin 59.85% Profit Margin -64.06% Avg. Volume 177,711 Target Price 11.83
Oper. Margin -60.31% Earnings Date Nov 7 Volume 89,146 Change -2.32%
About ClearPoint Neuro Inc.

ClearPoint Neuro, Inc. operates as a medical device company primarily in the United States. It develops and commercializes platforms for performing minimally invasive surgical procedures in the brain under magnetic resonance imaging guided interventions. The company offers ClearPoint system, an integrated system for the insertion of deep brain stimulation electrodes, biopsy needles, and laser catheters, as well as the infusion of pharmaceuticals into the brain. It has license and collaboration agreement with Clinical Laserthermia Systems AB; license and research agreement with Koninklijke Philips N.V., UCB Biopharma SRL, and University of California and San Francisco; and development and license agreement with NE Scientific, LLC. The company was formerly known as MRI Interventions, Inc. and changed its name to ClearPoint Neuro, Inc. in February 2020. ClearPoint Neuro, Inc. was incorporated in 1998 and is headquartered in Solana Beach, California.

ClearPoint Neuro Inc. News
08/26/24 ClearPoint Neuro Announces Early Repayment of $10 Million Note
08/07/24 ClearPoint Neuro Reports Second Quarter 2024 Results
07/17/24 ClearPoint Neuro to Announce Second Quarter 2024 Results August 7, 2024
07:45 AM ClearPoint Neuro Congratulates Partner Aspen Neuroscience on Use of the ClearPoint® Navigation System for All Enrolled Patients in ASPIRO Clinical Trial
07:30 AM Parkinson's Disease Clinical Trial Uses Intraoperative MRI to Guide Precision Implantation of Patients' Own Autologous Replacement Neurons
06/01/24 ClearPoint Neuro Announces Full Market Release of SmartFrame OR™ and ClearPoint PRISM® 3T Laser Therapy System
05/08/24 ClearPoint Neuro Inc (CLPT) Q1 2024 Earnings Call Transcript Highlights: Robust Revenue Growth ...
05/07/24 ClearPoint Neuro Reports First Quarter 2024 Results
05/02/24 ClearPoint Neuro to Present Novel Research and Exhibit at the 27th American Society of Gene & Cell Therapy Annual Meeting in Baltimore
04/29/24 ClearPoint Neuro Announces FDA Clearance of Prism Bone Anchor Accessory
04/24/24 ClearPoint Neuro Announces Initiation of Limited Market Release for the SmartFrame OR™ Stereotactic System
04/23/24 ClearPoint Neuro to Announce First Quarter 2024 Results May 7, 2024
04/19/24 Is There Now An Opportunity In ClearPoint Neuro, Inc. (NASDAQ:CLPT)?
04/16/24 ClearPoint Neuro Congratulates its Partner AviadoBio on First Patient Treated in its ASPIRE-FTD Clinical Trial Evaluating AVB-101 for Frontotemporal Dementia with GRN Mutations
03/19/24 ClearPoint Neuro Congratulates its Partner PTC Therapeutics on Completion of Biologics License Application Submission to FDA for Upstaza™ as a Treatment for AADC Deficiency
03/15/24 ClearPoint Neuro, Inc. (NASDAQ:CLPT) Annual Results: Here's What Analysts Are Forecasting For This Year
03/14/24 ClearPoint Neuro Full Year 2023 Earnings: Beats Expectations
03/12/24 ClearPoint Neuro Inc Reports Robust Revenue Growth in Q4 and Full-Year 2023
03/12/24 ClearPoint Neuro Reports Fourth Quarter and Full-Year 2023 Results
03/11/24 Journal of Neurosurgery Publication Demonstrates Distinct Advantages of ClearPoint Prism® Neuro Laser Therapy System
CLPT Chatroom

User Image RichSaunder Posted - 1 day ago

$CLPT Spaghetti man blocked me. Charmin soft.

User Image TJmaximus Posted - 2 days ago

$CLPT $13 was overpriced for this small niche spaghetti toss.

User Image capntrps Posted - 2 days ago

$CLPT I would say that this has plenty of room to drop, especially if the market gets bad. But, those would simply be good entry points for longer term investors so long as the company continues to execute.

User Image BiodegradableShxt Posted - 6 days ago

$CLPT Been a while Since the last PR Continue slayin’ But I’m just sayin’

User Image Fanofcls Posted - 1 week ago

$CLPT https://news.cision.com/cls/r/cls-announces-proposal-for-changes-to-the-board-of-directors,c4034858

User Image johnnygogogo Posted - 1 week ago

$CLPT CLS risk of selling to a competitor just went away w/ Peter Mantas joining the BoD

User Image RichSaunder Posted - 1 week ago

$CLPT

User Image TJmaximus Posted - 1 week ago

$CLPT I was mocked for trimming at $13...

User Image NY2CHI Posted - 1 week ago

$CLPT weeks like this in the broader market is why you always have to keep some dry powder…

User Image BiodegradableShxt Posted - 1 week ago

$CLPT Yeah keep selling morons. Don’t cry when this easily recovers next week.

User Image BiodegradableShxt Posted - 2 weeks ago

$CLPT Lfg!

User Image RichSaunder Posted - 2 weeks ago

$CLPT

User Image TJmaximus Posted - 2 weeks ago

$CLPT strategy is to rely on one of it's customers to end up with an approved therapy addressing a high volume indication... throw more spaghetti at the wall.

User Image DakotaQ Posted - 2 weeks ago

$CLPT around 400 people are going to be introduced to the real scope of this company tomorrow. Sorry if this creates any volatility. Totally possible nothing happens. https://open.substack.com/pub/leftfieldinvesting/p/clearpoint-neuros-drug-portfolio?utm_source=share&utm_medium=android&r=1n9zon

User Image degeneratetrader23 Posted - 2 weeks ago

$CLPT you'd think with the rsi where it is there'd be selling on a day like this. Ha!

User Image TJmaximus Posted - 08/29/24

$CLPT the spaghetti has been good to me, cmon Joe make another batch.

User Image Doozio Posted - 08/29/24

$CLPT full ☝️❤️ can’t lose wen a 🧠👀 becomes 🧠⏰

User Image degeneratetrader23 Posted - 08/29/24

$CLPT unrelenting. Only person selling is tj--and the shares he is selling aren't even real.

User Image TJmaximus Posted - 08/28/24

$CLPT anyone adding on the pullback?

User Image RichSaunder Posted - 08/28/24

$CLPT

User Image TJmaximus Posted - 08/27/24

$CLPT is there any spaghetti left to be thrown?

User Image MaverikIT Posted - 08/27/24

@net0trader @IsabellaDC @RonIsWrong Med device$ $DCTH $CLPT Off course $TMDX $PRCT

User Image jParkz Posted - 08/27/24

$CLPT News ClearPoint Neuro Inc. (NASDAQ: CLPT) Leading the Way in Tuesday Trading Based on Percentage Gain https://marketwirenews.com/news-releases/clearpoint-neuro-inc-nasdaq-clpt-leading-the-way-in--5906269275520326.html $CLPT

User Image LeftyT Posted - 08/27/24

$CMND and $CLPT and $ELTP are my only green plays today. It must be a day for C & E stocks only as everything else is ugly read today. :(

User Image DothThouEvenHoist Posted - 08/27/24

$CLPT TJ Maximus trim day!

User Image johnnygogogo Posted - 08/27/24

$CLPT $13 / share is what, a $360M mkt cap? Keeping some perspective here. I do think this is early days in the company’s eventual trajectory (and to not be fooled by a WoW or DoD percentage gain)

User Image Doozio Posted - 08/27/24

$clbt or $clpt in 🧠⏰♾️

User Image jParkz Posted - 08/27/24

News $CLPT Buy Recommendation Issued On CLPT By Lake Street https://marketwirenews.com/news-releases/buy-recommendation-issued-on-clpt-by-lake-street-4780232257068314.html $CLPT

User Image BiodegradableShxt Posted - 08/27/24

$CLPT Make it rain.

User Image johnnygogogo Posted - 08/27/24

$CLPT current list of largest med tech companies by market cap, fwiw: https://companiesmarketcap.com/medical-devices/largest-medical-device-companies-by-market-cap/

Analyst Ratings
Lake Street Buy Aug 27, 24
Stifel Buy Mar 13, 24
Stifel Buy Oct 24, 23
Lake Street Buy Aug 9, 23
Lake Street Buy Mar 18, 21
B. Riley Securities Buy Jul 17, 20
Insider Trades Relationship Date Transactions Cost($) #Shares Value($) #Share Own SEC Form 4
Piferi Peter G. Chief Operating Offi.. Chief Operating Officer Aug 20 Option 3.47 8,929 30,984 68,168 08/20/21